Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Surjeet Singh

BSc, PhD

Clinical Trials Manager

I am the SITU Trials Manager in NDS at the University of Oxford.  I obtained a PhD degree in Non-Viral Gene Therapy from the School of Chemistry, University of Birmingham.  After my PhD I worked as formulation scientist at Aphton Corporation and led the formulation team at Glide Pharma.  At Glide Pharma I was highly involved in setting up and running 2 Phase 1 clinical trials including the GMP manufacture of the CTIMP.  I joined NDORMS in 2010 and managed the multi-centre vasculitis study, TABUL (Chief Investigator - Prof Raashid Luqmani),  I am also a member of the Oxford C Ethics Committee.  I joined SITU in November 2014.

False False

Recent Publications

5 View 17 more »